Rep. Richard McCormick Buys UnitedHealth Group Incorporated (NYSE:UNH) Shares

Representative Richard McCormick (R-Georgia) recently bought shares of UnitedHealth Group Incorporated (NYSE:UNH). In a filing disclosed on December 09th, the Representative disclosed that they had bought between $1,001 and $15,000 in UnitedHealth Group stock on November 5th.

Representative Richard McCormick also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of PepsiCo (NASDAQ:PEP) on 11/5/2025.
• Purchased $1,001 – $15,000 in shares of Berkshire Hathaway (NYSE:BRK.B) on 11/5/2025.
• Purchased $1,001 – $15,000 in shares of Medtronic (NYSE:MDT) on 11/5/2025.
• Purchased $1,001 – $15,000 in shares of Realty Income (NYSE:O) on 11/5/2025.
• Purchased $1,001 – $15,000 in shares of McDonald’s (NYSE:MCD) on 11/5/2025.
• Purchased $1,001 – $15,000 in shares of Intercontinental Exchange (NYSE:ICE) on 11/5/2025.
• Purchased $1,001 – $15,000 in shares of Costco Wholesale (NASDAQ:COST) on 11/5/2025.
• Purchased $1,001 – $15,000 in shares of Johnson & Johnson (NYSE:JNJ) on 11/5/2025.
• Purchased $1,001 – $15,000 in shares of Microsoft (NASDAQ:MSFT) on 11/5/2025.
• Purchased $1,001 – $15,000 in shares of Cisco Systems (NASDAQ:CSCO) on 11/5/2025.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $341.83 on Monday. The stock has a fifty day moving average of $339.84 and a 200-day moving average of $317.20. The stock has a market cap of $309.65 billion, a PE ratio of 17.84, a price-to-earnings-growth ratio of 2.23 and a beta of 0.43. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.82 and a current ratio of 0.82. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $606.36.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The business had revenue of $113.16 billion during the quarter, compared to analyst estimates of $113.19 billion. During the same quarter in the previous year, the firm earned $7.15 EPS. The company’s quarterly revenue was up 12.2% compared to the same quarter last year. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 16th. Stockholders of record on Monday, December 8th will be issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date of this dividend is Monday, December 8th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 46.14%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the company. Mizuho lifted their price objective on UnitedHealth Group from $300.00 to $430.00 and gave the company an “outperform” rating in a research note on Thursday, October 9th. Morgan Stanley boosted their price objective on UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a report on Friday, September 12th. TD Cowen lifted their target price on shares of UnitedHealth Group from $335.00 to $338.00 and gave the company a “hold” rating in a research report on Thursday, October 30th. Royal Bank Of Canada increased their price objective on UnitedHealth Group from $286.00 to $408.00 and gave the company an “outperform” rating in a research report on Wednesday, October 29th. Finally, Weiss Ratings raised UnitedHealth Group from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, October 24th. Seventeen equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have given a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $385.54.

Institutional Investors Weigh In On UnitedHealth Group

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in UNH. Saranac Partners Ltd purchased a new stake in shares of UnitedHealth Group during the third quarter worth about $4,998,000. Strategic Investment Solutions Inc. IL increased its position in UnitedHealth Group by 766.0% during the 3rd quarter. Strategic Investment Solutions Inc. IL now owns 1,732 shares of the healthcare conglomerate’s stock valued at $598,000 after purchasing an additional 1,532 shares during the period. Severin Investments LLC purchased a new stake in shares of UnitedHealth Group in the 3rd quarter worth about $598,000. Allworth Financial LP increased its position in shares of UnitedHealth Group by 3.5% during the third quarter. Allworth Financial LP now owns 94,077 shares of the healthcare conglomerate’s stock valued at $32,485,000 after buying an additional 3,194 shares during the period. Finally, Swiss Life Asset Management Ltd lifted its holdings in UnitedHealth Group by 6.5% in the third quarter. Swiss Life Asset Management Ltd now owns 291,853 shares of the healthcare conglomerate’s stock worth $100,777,000 after buying an additional 17,684 shares during the period. 87.86% of the stock is currently owned by institutional investors.

About Representative McCormick

Rich McCormick (Republican Party) is a member of the U.S. House, representing Georgia’s 7th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

McCormick (Republican Party) is running for re-election to the U.S. House to represent Georgia’s 7th Congressional District. He declared candidacy for the 2026 election.

Rich McCormick lives in Suwanee, Georgia. McCormick served in the U.S. Marine Corps and the U.S. Navy. He earned an M.B.A. from National University and an M.D. from Morehouse School of Medicine. McCormick’s career experience includes working as an emergency medicine physician with Gwinnett Medical Center and Northside Hospital, a Marine officer instructor with Georgia Tech and Morehouse College, and a pilot.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.